Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Emisphere's carriers for oral delivery of proteins covered by patent

March 10, 1997

ImaRx reports discoveries related to gene expression enhancement

March 10, 1997

Incyte's LifeSeq database licensed to another top pharmaceutical company

March 7, 1997

MorphoSys/P&U drug and target discovery collaboration

March 6, 1997

Cell Genesys licenses gene activation technology

March 6, 1997

Protein Design Labs grants license to Biogen for humanized antibodies

March 5, 1997

GenPharm and Centocor to codevelop human antibodies

March 5, 1997

Vyrex and SeqWright collaborate to develop CD-Tagging technology

March 4, 1997

Incyte and OncorMed to collaborate on clinical genomics

March 3, 1997

Phogen formed to investigate new drug delivery concept

March 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...